NDSRI analysis
Brightlabs has developed and validated multiple methods (GC-MS/MS & LC-MS/MS) to determine low level concentrations of Nitrosamines and NDSRIs in Drug Products
Brightlabs
-
Country/Region:Netherlands
-
On CPHI since:2021
-
Certificates:2
-
Employees:25 - 49